Inventor · disambiguated record
Pier Paolo Pandolfi
Also filed as: PANDOLFI PIER P · PANDOLFI PIER PAOLO
15 granted patents·11 pending applications·202 citations·filing 1998–2022
93Inventor score
Files withBETH ISRAEL DEACONESS MEDICAL CT INC13SLOAN KETTERING INST CANCER9BETH ISRAEL HOSPITAL1BETH ISREAL DEACONESS MEDICAL CENTER1PANDOLFI PIER PAOLO1
Top patents by PatentIndex Score
26 records- 0195US6723351B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 2003·Granted Apr 20, 2004·42 cites·64 claims
- 0288US8273379B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolWARRELL JR RAYMOND P·Filed 2010·Granted Sep 25, 2012·4 cites·20 claims
- 0388US7879364B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 2005·Granted Feb 1, 2011·7 cites·22 claims
- 0488US6982096B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 2004·Granted Jan 3, 2006·13 cites·6 claims
- 0587US6884439B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 2004·Granted Apr 26, 2005·11 cites·21 claims
- 0685US6855339B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 2004·Granted Feb 15, 2005·9 cites·20 claims
- 0783US6770304B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 1998·Granted Aug 3, 2004·32 cites·7 claims
- 0882US6262116B1Transcription therapy for cancersSLOAN KETTERING INST CANCER·Filed 1998·Granted Jul 17, 2001·70 cites·3 claims
- 0981US10443055B2Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancerBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Oct 15, 2019·3 cites·13 claims
- 1081US6861076B2Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 2004·Granted Mar 1, 2005·8 cites·20 claims
- 1173US9822358B2Treatment of cancers with micro-RNA inhibitorsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2014·Granted Nov 21, 2017·2 cites·10 claims
- 1262US11753639B2Micro-RNA and obesityBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Sep 12, 2023·0 cites·18 claims
- 1356US11499152B2Inhibitors of micro-RNA 22BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Granted Nov 15, 2022·0 cites·5 claims
- 1456US10131905B2Micro-RNA inhibitors and their uses in diseasePANDOLFI PIER PAOLO·Filed 2012·Granted Nov 20, 2018·1 cites·6 claims
- 1556US2023181613A1Inhibitors of micro-rna 22BETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2022·Application pending·0 cites
- 1655US2003099719A1Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprolSLOAN KETTERING INST CANCER·Filed 2002·Application pending·0 cites
- 1755US2023024461A1Methods for dual dna/protein tagging of open chromatinBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2020·Application pending·0 cites
- 1853US11274301B2Micro-RNA inhibitors and their uses in diseaseBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Granted Mar 15, 2022·0 cites·10 claims
- 1953US2020140859A1COMPOUNDS THAT TARGET MYC microRNA RESPONSIVE ELEMENTS FOR THE TREATMENT OF MYC-ASSOCIATED CANCERBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Application pending·0 cites
- 2050US2021301349A1Compositions and methods for treating a tumor suppressor deficient cancerBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Application pending·0 cites
- 2146US2018105813A1Treatment of Cancers with Micro-RNA InhibitorsBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Application pending·0 cites
- 2243US2017298347A1NOVEL FUSION-CIRCULAR RNAs AND USES THEREOFBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Application pending·0 cites
- 2343US2021277102A1Compositions and methods for treating a tumor suppressor deficient cancerBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2017·Application pending·0 cites
- 2441US2021002649A1Compositions and methods for treating cancerBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2019·Application pending·0 cites
- 2541US2015079590A1Characterization and analysis of the composition and dynamics of the mammalian riboproteomeBETH ISRAEL HOSPITAL·Filed 2014·Application pending·0 cites
- 2627US2019374506A1Compositions and methods for treating cancerBETH ISREAL DEACONESS MEDICAL CENTER·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pier Paolo Pandolfi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →